Works matching AU Brainard, Diana M.

Results: 47
    1

    Ledipasvir‐sofosbuvir for treating Japanese patients with chronic hepatitis C virus genotype 2 infection.

    Published in:
    Liver International, 2018, v. 38, n. 9, p. 1552, doi. 10.1111/liv.13685
    By:
    • Asahina, Yasuhiro;
    • Itoh, Yoshito;
    • Ueno, Yoshiyuki;
    • Matsuzaki, Yasushi;
    • Takikawa, Yasuhiro;
    • Yatsuhashi, Hiroshi;
    • Genda, Takuya;
    • Ikeda, Fusao;
    • Matsuda, Takuma;
    • Dvory‐Sobol, Hadas;
    • Jiang, Deyuan;
    • Massetto, Benedetta;
    • Osinusi, Anu O.;
    • Brainard, Diana M.;
    • McHutchison, John G.;
    • Kawada, Norifumi;
    • Enomoto, Nobuyuki
    Publication type:
    Article
    2

    Identification of hepatitis C virus 2k/1b intergenotypic recombinants in Georgia.

    Published in:
    Liver International, 2018, v. 38, n. 3, p. 451, doi. 10.1111/liv.13540
    By:
    • Zakalashvili, Mamuka;
    • Zarkua, Jaba;
    • Zangurashvili, Lela;
    • Kankia, Nino;
    • Jashiashvili, Nino;
    • Lomidze, Maka;
    • Telia, Tengiz;
    • Kerashvili, Vakhtang;
    • Zhamutashvili, Maia;
    • Abramishvili, Nikoloz;
    • Rtskhiladze, Irakli;
    • Metreveli, David;
    • Weizenegger, Michael;
    • Bartel, Jan;
    • Raabe, Monika;
    • Hedskog, Charlotte;
    • Chodavarapu, Krishna;
    • Brainard, Diana M.;
    • McHutchison, John G.;
    • Mo, Hongmei
    Publication type:
    Article
    3
    4

    A phase 3b study of sofosbuvir plus ribavirin in Taiwanese patients with chronic genotype 2 hepatitis C virus infection.

    Published in:
    Liver International, 2016, v. 36, n. 8, p. 1101, doi. 10.1111/liv.13082
    By:
    • Kao, Jia ‐ Horng;
    • Chien, Rong ‐ Nan;
    • Chang, Ting ‐ Tsung;
    • Peng, Cheng ‐ Yuan;
    • Hu, Tsung ‐ Hui;
    • Lo, Gin ‐ Ho;
    • Wang, Horng ‐ Yuan;
    • Chen, Jyh ‐ Jou;
    • Yang, Jenny C.;
    • Knox, Steven J.;
    • Han, Lingling;
    • Mo, Hongmei;
    • Mathias, Anita;
    • Brainard, Diana M.;
    • Sheen, I ‐ Shyan;
    • Hsu, Yu ‐ Chun;
    • Chu, Chi ‐ Jen;
    • Chuang, Wan ‐ Long
    Publication type:
    Article
    5
    6
    7

    Weight Gain Following Initiation of Antiretroviral Therapy: Risk Factors in Randomized Comparative Clinical Trials.

    Published in:
    Clinical Infectious Diseases, 2020, v. 71, n. 6, p. 1379, doi. 10.1093/cid/ciz999
    By:
    • Sax, Paul E;
    • Erlandson, Kristine M;
    • Lake, Jordan E;
    • Mccomsey, Grace A;
    • Orkin, Chloe;
    • Esser, Stefan;
    • Brown, Todd T;
    • Rockstroh, Jürgen K;
    • Wei, Xuelian;
    • Carter, Christoph C;
    • Zhong, Lijie;
    • Brainard, Diana M;
    • Melbourne, Kathleen;
    • Das, Moupali;
    • Stellbrink, Hans-Jürgen;
    • Post, Frank A;
    • Waters, Laura;
    • Koethe, John R
    Publication type:
    Article
    8

    Baseline characteristics associated with clinical improvement and mortality in hospitalized patients with severe COVID-19 treated with remdesivir.

    Published in:
    Infection & Chemotherapy, 2020, v. 52, p. S384
    By:
    • Mi Young Ahn;
    • Marks, Kristen;
    • Hojat, Leila;
    • Huhn, Gregory;
    • Degnan, Kathleen;
    • Subramanian, Aruna;
    • Galli, Massimo;
    • Bruno, Raffaele;
    • Muñoz, Jose;
    • Hyland, Robert R.;
    • Xuelian Wei;
    • Blair, Christiana;
    • Huyen Cao;
    • SenGupta, Devi;
    • Osinusi, Anu O.;
    • Brainard, Diana M.;
    • Ogbuagu, Onyema;
    • Robinson, Philip
    Publication type:
    Article
    9

    Racial/ethnic Disparities Not Observed in Clinical Outcomes with Remdesivir Treatment.

    Published in:
    Infection & Chemotherapy, 2020, v. 52, p. S382
    By:
    • Jeong-a Lee;
    • Mullane, Kathleen;
    • Criner, Gerard;
    • Richterman, Aaron G.;
    • Nahass, Ronald G.;
    • Jain, Mamta;
    • Aberg, Judith;
    • Gottlieb, Robert L.;
    • Elboudwarej, Emon;
    • Yuan Tian;
    • SenGupta, Devi;
    • Hyland, Robert H.;
    • Chokkalingam, Anand P.;
    • Osinusi, Anu O.;
    • Brainard, Diana M.;
    • Towner, William
    Publication type:
    Article
    10
    11

    Deferred treatment with a fixed‐dose combination of sofosbuvir‐velpatasvir for chronic hepatitis C virus genotype 1, 2, 4 and 6 infection.

    Published in:
    Journal of Viral Hepatitis, 2019, v. 26, n. 10, p. 1229, doi. 10.1111/jvh.13159
    By:
    • Asselah, Tarik;
    • Shafran, Stephen D.;
    • Bourgeois, Stefan;
    • Lai, Ching‐Lung;
    • Mathurin, Philippe;
    • Willems, Bernard;
    • Nguyen, Mindie H.;
    • Davis, Mitchell N.;
    • Huang, K. C.;
    • Svarovskaia, Evguenia;
    • Osinusi, Anu;
    • McNally, John;
    • Brainard, Diana M.;
    • Shaikh, Obaid S.;
    • Tran, Tram T.
    Publication type:
    Article
    12
    13
    14
    15

    Sofosbuvir and Ribavirin for Hepatitis C in Patients With HIV Coinfection.

    Published in:
    JAMA: Journal of the American Medical Association, 2014, v. 312, n. 4, p. 353, doi. 10.1001/jama.2014.7734
    By:
    • Sulkowski, Mark S.;
    • Naggie, Susanna;
    • Lalezari, Jacob;
    • Fessel, Walford Jeffrey;
    • Mounzer, Karam;
    • Shuhart, Margaret;
    • Luetkemeyer, Anne F.;
    • Asmuth, David;
    • Gaggar, Anuj;
    • Liyun Ni;
    • Svarovskaia, Evguenia;
    • Brainard, Diana M.;
    • Symonds, William T.;
    • Subramanian, G. Mani;
    • McHutchison, John G.;
    • Rodriguez-Torres, Maribel;
    • Dieterich, Douglas
    Publication type:
    Article
    16
    17

    Sofosbuvir With Velpatasvir in Treatment-Naive Noncirrhotic Patients With Genotype 1 to 6 Hepatitis C Virus Infection: A Randomized Trial.

    Published in:
    2015
    By:
    • Everson, Gregory T.;
    • Towner, William J.;
    • Davis, Mitchell N.;
    • Wyles, David L.;
    • Nahass, Ronald G.;
    • Thuluvath, Paul J.;
    • Etzkorn, Kyle;
    • Hinestrosa, Federico;
    • Myron Tong;
    • Rabinovitz, Mordechai;
    • McNally, John;
    • Brainard, Diana M.;
    • Han, Lingling;
    • Doehle, Brian;
    • McHutchison, John G.;
    • Morgan, Timothy;
    • Chung, Raymond T.;
    • Tran, Tram T.;
    • Tong, Myron
    Publication type:
    journal article
    18

    Sofosbuvir Plus Velpatasvir Combination Therapy for Treatment-Experienced Patients With Genotype 1 or 3 Hepatitis C Virus Infection: A Randomized Trial.

    Published in:
    2015
    By:
    • Pianko, Stephen;
    • Flamm, Steven L.;
    • Shiftman, Mitchell L.;
    • Kumar, Sonal;
    • Strasser, Simone I.;
    • Dore, Gregory J.;
    • McNally, John;
    • Brainard, Diana M.;
    • Han, Lingling;
    • Doehle, Brian;
    • Mogalian, Erik;
    • McHutchison, John G.;
    • Rabinovitz, Mordechai;
    • Towner, William J.;
    • Gane, Edward J.;
    • Stedman, Catherine A. M.;
    • Reddy, K. Rajender;
    • Roberts, Stuart K.;
    • Shiffman, Mitchell L
    Publication type:
    journal article
    19

    Ledipasvir/Sofosbuvir for 8 Weeks to Treat Acute Hepatitis C Virus Infections in Men With Human Immunodeficiency Virus Infections: Sofosbuvir-Containing Regimens Without Interferon for Treatment of Acute HCV in HIV-1 Infected Individuals.

    Published in:
    Clinical Infectious Diseases, 2019, v. 69, n. 3, p. 514, doi. 10.1093/cid/ciy913
    By:
    • Naggie, Susanna;
    • Fierer, Daniel S;
    • Hughes, Michael D;
    • Kim, Arthur Y;
    • Luetkemeyer, Annie;
    • Vu, Vincent;
    • Roa, Jhoanna;
    • Rwema, Steve;
    • Brainard, Diana M;
    • McHutchison, John G;
    • Peters, Marion G;
    • Kiser, Jennifer J;
    • Marks, Kristen M;
    • Chung, Raymond T;
    • Team, Acquired Immunodeficiency Syndrome Clinical Trials Group (ACTG) A5327 Study
    Publication type:
    Article
    20
    21
    22

    Ledipasvir-Sofosbuvir Plus Ribavirin in Treatment-Naive Patients With Hepatitis C Virus Genotype 3 Infection: An Open-Label Study.

    Published in:
    Clinical Infectious Diseases, 2017, v. 65, n. 1, p. 13, doi. 10.1093/cid/cix289
    By:
    • Feld, Jordan J.;
    • Ramji, Alnoor;
    • Shafran, Stephen D.;
    • Willems, Bernard;
    • Marotta, Paul;
    • Huchet, Emmanuelle;
    • Vachon, Marie-Louise;
    • Svarovskaia, Evguenia S.;
    • Huang, K. C.;
    • Hyland, Robert H.;
    • Yun, Chohee;
    • Massetto, Benedetta;
    • Brainard, Diana M.;
    • McHutchison, John G.;
    • Tam, Edward;
    • Bailey, Robert;
    • Cooper, Curtis;
    • Yoshida, Eric M.;
    • Greenbloom, Susan;
    • Elkhashab, Magdy
    Publication type:
    Article
    23

    Sofosbuvir and Velpatasvir for the Treatment of Hepatitis C Virus in Patients Coinfected With Human Immunodeficiency Virus Type 1: An Open-Label, Phase 3 Study.

    Published in:
    Clinical Infectious Diseases, 2017, v. 65, n. 1, p. 6, doi. 10.1093/cid/cix260
    By:
    • Wyles, David;
    • Bräu, Norbert;
    • Kottili, Shyam;
    • Daar, Eric S.;
    • Ruane, Peter;
    • Workowski, Kimberly;
    • Luetkemeyer, Anne;
    • Adeyemi, Oluwatoyin;
    • Kim, Arthur Y.;
    • Doehle, Brian;
    • Huang, K. C.;
    • Mogalian, Erik;
    • Osinusi, Anu;
    • McNally, John;
    • Brainard, Diana M.;
    • McHutchison, John G.;
    • Naggie, Susanna;
    • Sulkowski, Mark
    Publication type:
    Article
    24
    25
    26
    27

    Efficacy and Safety of Sofosbuvir/Velpatasvir in Patients With Chronic Hepatitis C Virus Infection Receiving Opioid Substitution Therapy: Analysis of Phase 3 ASTRAL Trials.

    Published in:
    Clinical Infectious Diseases, 2016, v. 63, n. 11, p. 1479, doi. 10.1093/cid/ciw579
    By:
    • Grebely, Jason;
    • Dore, Gregory J.;
    • Zeuzem, Stefan;
    • Aspinall, Richard J.;
    • Fox, Raymond;
    • Han, Lingling;
    • McNally, John;
    • Osinusi, Anu;
    • Brainard, Diana M.;
    • Subramanian, G. Mani;
    • Natha, Macky;
    • Foster, Graham R.;
    • Mangia, Alessandra;
    • Sulkowski, Mark;
    • Feld, Jordan J.
    Publication type:
    Article
    28

    Efficacy and Safety of Ledipasvir/Sofosbuvir With and Without Ribavirin in Patients With Chronic HCV Genotype 1 Infection Receiving Opioid Substitution Therapy: Analysis of Phase 3 ION Trials.

    Published in:
    Clinical Infectious Diseases, 2016, v. 63, n. 11, p. 1405, doi. 10.1093/cid/ciw580
    By:
    • Grebely, Jason;
    • Mauss, Stefan;
    • Brown, Ashley;
    • Bronowicki, Jean-Pierre;
    • Puoti, Massimo;
    • Wyles, David;
    • Natha, Macky;
    • Yanni Zhu;
    • Junming Yang;
    • Kreter, Bruce;
    • Brainard, Diana M.;
    • Chohee Yun;
    • Carr, Val;
    • Dore, Gregory J.
    Publication type:
    Article
    29
    30

    Efficacy and safety of sofosbuvir-velpatasvir with or without ribavirin in HCV-infected Japanese patients with decompensated cirrhosis: an open-label phase 3 trial.

    Published in:
    2019
    By:
    • Takehara, Tetsuo;
    • Sakamoto, Naoya;
    • Nishiguchi, Shuhei;
    • Ikeda, Fusao;
    • Tatsumi, Tomohide;
    • Ueno, Yoshiyuki;
    • Yatsuhashi, Hiroshi;
    • Takikawa, Yasuhiro;
    • Kanda, Tatsuo;
    • Sakamoto, Minoru;
    • Tamori, Akihiro;
    • Mita, Eiji;
    • Chayama, Kazuaki;
    • Zhang, Gulan;
    • De-Oertel, Shampa;
    • Dvory-Sobol, Hadas;
    • Matsuda, Takuma;
    • Stamm, Luisa M.;
    • Brainard, Diana M.;
    • Tanaka, Yasuhito
    Publication type:
    journal article
    31

    Persistence of Virologic Response after Liver Transplant in Hepatitis C Patients Treated with Ledipasvir / Sofosbuvir Plus Ribavirin Pretransplant.

    Published in:
    Annals of Hepatology: Official Journal of the Mexican Association of Hepatology, 2017, v. 16, n. 3, p. 375, doi. 10.5604/01.3001.0009.8592
    By:
    • Yoshida, Eric M.;
    • Kwo, Paul;
    • Agarwal, Kosh;
    • Duvoux, Christophe;
    • Durand, François;
    • Peck-Radosavljevic, Markus;
    • Lilly, Leslie;
    • Willems, Bernard;
    • Vargas, Hugo;
    • Kumar, Princy;
    • Brown Jr., Robert S.;
    • Horsmans, Yves;
    • De-Oertel, Shampa;
    • Arterburn, Sarah;
    • Dvory-Sobol, Hadas;
    • Brainard, Diana M.;
    • McHutchison, John G.;
    • Terrault, Norah;
    • Rizzetto, Mario;
    • Müllhaupt, Beat
    Publication type:
    Article
    32
    33

    Sofosbuvir/velpatasvir for the treatment of HCV: excellent results from a phase-3, open-label study in Russia and Sweden.

    Published in:
    Infectious Diseases, 2019, v. 51, n. 2, p. 131, doi. 10.1080/23744235.2018.1535186
    By:
    • Isakov, Vasily;
    • Chulanov, Vladimir;
    • Abdurakhmanov, Dzhamal;
    • Burnevich, Eduard;
    • Nurmukhametova, Elena;
    • Kozhevnikova, Galina;
    • Gankina, Natalya;
    • Zhuravel, Sergey;
    • Romanova, Svetlana;
    • Hyland, Robert H.;
    • Lu, Sophia;
    • Svarovskaia, Evguenia S.;
    • McNally, John;
    • Brainard, Diana M.;
    • Ivashkin, Vladimir;
    • Morozov, Vyacheslav;
    • Bakulin, Igor;
    • Lagging, Martin;
    • Zhdanov, Konstantin;
    • Weiland, Ola
    Publication type:
    Article
    34

    1288. Bone Safety Outcomes with F/TAF vs. F/TDF for PrEP in the DISCOVER Trial.

    Published in:
    Open Forum Infectious Diseases, 2019, v. 6, p. S464, doi. 10.1093/ofid/ofz360.1151
    By:
    • Wohl, David;
    • Ruane, Peter;
    • Hosek, Sybil;
    • Creticos, Catherine;
    • Morris, Sheldon;
    • Phoenix, John;
    • Ramgopal, Moti;
    • Brinson, Cynthia;
    • Tremblay, Cecile;
    • Carter, Christoph C;
    • Wong, Pamela;
    • Brainard, Diana M;
    • McCallister, Scott;
    • Das, Moupali;
    • Thompson, Melanie A
    Publication type:
    Article
    35

    318. Tenofovir Alafenamide (TAF) vs. Tenofovir Disoproxil Fumarate (TDF) in Hispanic/Latinx and Black Participants: Efficacy, Bone and Renal Safety Results from a Pooled Analysis of 7 Clinical Trials.

    Published in:
    Open Forum Infectious Diseases, 2019, v. 6, p. S168, doi. 10.1093/ofid/ofz360.391
    By:
    • DeJesus, Edwin;
    • Villanueva, Jaime Federico Andrade;
    • Lopez, Jose Ramon Arribas;
    • Brinson, Cynthia;
    • Crofoot, Gordon;
    • Daar, Eric S;
    • Koenig, Ellen;
    • Podzamczer, Daniel;
    • Ramgopal, Moti;
    • Santana, Jorge;
    • Santiago, Lizette;
    • Tebas, Pablo;
    • Zorrilla, Carmen;
    • Guo, Susan;
    • Liu, Ya-Pei;
    • Zhong, Lijie;
    • Brainard, Diana M;
    • Carter, Christoph C;
    • Temme, Lauren;
    • Das, Moupali
    Publication type:
    Article
    36
    37

    2490. Longer-Term Safety and Efficacy of Elvitegravir/Cobicistat/Emtricitabine/Tenofovir Alafenamide in Virologically Suppressed Adults Living With HIV and End-Stage Renal Disease on Chronic Hemodialysis.

    Published in:
    Open Forum Infectious Diseases, 2019, v. 6, p. S864, doi. 10.1093/ofid/ofz360.2168
    By:
    • Eron, Joseph J;
    • Lelievre, Jean-Daniel;
    • Kalayjian, Robert;
    • Slim, Jihad;
    • Wurapa, Anson K;
    • Stephens, Jeffrey L;
    • McDonald, Cheryl;
    • Cua, Eric;
    • Wilkin, Arjun;
    • McKellar, Mehri;
    • Cox, Stephanie;
    • Majeed, Sophia;
    • Blair, Christiana;
    • Carter, Christoph C;
    • SenGupta, Devi;
    • Brainard, Diana M;
    • Das, Moupali
    Publication type:
    Article
    38
    39
    40
    41
    42
    43
    44
    45
    46
    47